当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3261647
自主品牌
已选条件
-
T6136CanertinibPD-183805；CI-1033；卡纽替尼
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
价 格：￥电议型 号：T6136产 地：中国大陆
-
T2501Canertinib dihydrochlorideCI-1033 dihydrochloride；Canertinib；PD-183805 dihydrochloride；卡奈替尼二盐酸盐
Canertinib dihydrochloride is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities.
价 格：￥电议型 号：T2501产 地：中国大陆
-
T2501Canertinib dihydrochlorideCanertinib dihydrochloride,CI-1033 dihydrochloride,PD-183805 dihydrochlori
Canertinib dihydrochloride is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities.
价 格：￥电议型 号：T2501产 地：美洲
-
T6136CanertinibCanertinib,PD-183805,CI-1033
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
价 格：￥电议型 号：T6136产 地：美洲
-
T6136Canertinib卡纽替尼PD-183805|||CI-1033|||卡纽替尼
Canertinib (CI-1033) is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
价 格：￥电议型 号：T6136产 地：中国大陆
-
T2501Canertinib dihydrochloride卡奈替尼二盐酸盐CI-1033 dihydrochloride|||PD-183805 dihydrochloride|||Canertinib||
Canertinib dihydrochloride (PD-183805 dihydrochloride) is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities.
价 格：￥电议型 号：T2501产 地：中国大陆
